• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,686.95
    -222.70 (--0.41%)
  • Jio Platforms
    1,438.95 1,490.00(%)
  • NSE
    1,775.20 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,320.00(%)
  • Anand Rathi Wea.
    2,246.45 1,354.00(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Ather Energy
    1,782.05 1,782.05(%)
  • Laurus Labs
    2,392.00 2,392.00(%)
  • Sagility
    41.79 35.82(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Indian Hotels Co
    824.00 824.00(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • ICICI AMC
    2,688.00 2,528.90(%)
  • Hexaware Tech.
    497.95 400.35(%)
  • Suzlon Energy
    33.21 33.21(%)
  • Godrej Consumer
    777.65 777.65(%)
  • Diamond Power
    350.00 406.80(%)
  • Equitas Sma. Fin
    47.26 47.26(%)
  • APL Apollo Tubes
    2,161.00 1,691.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Supriya Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75656.0
  • ISIN : INE07RO01027
847.30 -22 (-2.53%)
  • As on 31 Oct 2026 (EOD)

  • Today’s Low

    841.80

  • Today’s High

    880.45

  • Open

    869.30

  • Perv Close

    869.30

  • 52W Low

    545.50

  • 52W High

    1,085.00

Key Indicators

  • P/E(TTM)

    34.27

  • Mar.Cap (₹Cr.)

    6,819.31

  • Div & Yield %

    0.12

  • Book Value(₹)

    148.82

  • Debt-Equity Ratio

    -2.53

  • AGM Date

    30-Oct-2026

  • EPS

    24.69

  • P/E Ratio

    34.27

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    6,819.31

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.10

  • BV (₹)

    148.80

  • Sales( ₹ in Cr.)

    827.88

  • NP (in Cr.)

    209.15

  • NP Var(%)

    11.0

  • Div%

    50.0

  • CPS (₹)

    29.50

  • EPS (₹)

    26.00

  • Traded Value (₹ in Lakhs)

    6,810.45

  • 52 Week High

    1,085.00

  • 52 Week Low

    545.50

  • Price BSE

    846.0

  • Price NSE

    847.00

  • Market Capital( in Cr.)

    6,810.45

  • P/C Ratio

    28.70

  • P/E Ratio

    32.60

  • Price Vs.BV

    26.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 914.72 781.92 646.93 516.47 588.52 430.97
Excise Duty 86.85 85.44 76.59 55.53 58.47 39.76
Net Sales 827.87 696.48 570.34 460.94 530.05 391.21
Other Income 11.49 9.82 10.64 9.49 7.58 5.01
Stock Adjustments 11.09 21.26 -30.31 6.51 3.03 12.44
Total Income 850.45 727.56 550.67 476.94 540.66 408.66
EXPENDITURE :            
Raw Materials 265.12 232.44 191.43 187.32 198.83 140.57
Power and Fuel Cost 29.77 24.80 21.37 20.95 14.07 9.24
Employee Cost 96.68 80.52 67.64 55.58 49.08 32.76
Other Manufacturing Expenses 80.61 51.81 35.68 28.87 18.44 13.15
Selling and Administration Expenses 58.68 54.65 38.10 37.32 33.83 31.88
Miscellaneous Expenses 13.64 12.61 9.80 8.51 4.84 2.92
Employee Benefit Expenses 96.68 80.52 67.64 55.58 49.08 32.76
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 544.49 456.83 364.01 338.55 319.09 230.51
Operating Profit 305.96 270.73 186.65 138.38 221.56 178.15
Interest 2.77 1.81 5.15 3.08 4.20 4.08
Gross Profit 303.19 268.92 181.50 135.30 217.36 174.07
Depreciation 28.41 20.44 15.81 11.82 10.12 6.76
Profit Before Tax 274.78 248.48 165.69 123.48 207.24 167.31
Current Tax 61.43 56.66 37.10 30.68 52.19 43.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.23 3.87 9.48 2.95 3.25 0.69
Reported Net Profit 209.12 187.96 119.11 89.86 151.81 123.59
Extraordinary Items -0.03 0.00 0.00 -0.08 0.00 0.00
Adjusted Net Profit 209.15 187.96 119.11 89.94 151.81 123.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 781.97 600.45 486.16 401.13 253.72 134.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 8.05 6.44 4.83 4.83 4.39 3.96
P & L Balance carried down 983.04 781.97 600.45 486.16 401.13 253.72
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 40.00 30.00 30.00 27.00
Dividend Per Share(Rs) 1.00 1.00 0.80 0.60 0.60 0.54
Earnings Per Share-Unit Curr 25.98 23.35 14.80 11.16 18.86 16.89
Earnings Per Share(Adj)-Unit Curr 25.98 23.35 14.80 11.16 18.86 -
Book Value 148.81 123.84 101.31 86.91 76.50 36.70
Book Value(Adj)-Unit Curr 148.81 123.84 101.31 86.91 76.50 -

Shareholding Pattern

  • Promoter Group

    68.30%

  • Public Share Holding

    31.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,967,815 68.30 54,967,815 5
Partnership Firms-Indian (Promoter & Group) 10 0.00 10 1
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,967,825 68.30 54,967,825 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,186,808 6.44 5,186,808 74
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,909,860 2.37 1,909,860 2
Mutual Funds / UTI 1,027,484 1.28 1,027,484 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,461,362 1.82 1,461,362 9
Trusts 100 0.00 100 1
Venture Capital Funds 0 0.00 0 0
Sub total 9,585,614 11.91 9,585,614 95
2] Non Institution
Bodies Corporate 2,038,110 2.53 2,038,110 461
Clearing Members 18,687 0.02 18,687 23
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 834,212 1.04 834,212 2,007
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 527,375 0.66 527,375 1,254
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,004,924 1.25 1,004,924 6
Individuals holding nominal share capital up to Rs. 1 lakh 11,411,994 14.18 11,411,994 74,677
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 696 0.00 696 2
Others 0 0.00 0 0
Sub Total 15,929,361 19.79 15,929,361 78,460
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 80,482,800 100.00 80,482,800 78,561

Company Background

Supriya Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Supriya Lifescience Ltd
  • BSE Code : 75656.0
  • ISIN : INE07RO01027

  • Incorporation Year

    2008

  • Registered Office

    207/208 Udyog Bhavan
    Sonawala Road Goregaon (East), Mumbai,
    Maharashtra-400063

  • Telephone

    91-22-40332727

  • FAX

  • Chairman

    Satish Waman Wagh

  • Managing Director

    Satish Waman Wagh

  • Company Secretary

    Prachi Sathe

  • Auditor

    Kakaria & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Supriya Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Supriya Lifesci. 846.20 839.36 914.72 34.33 25.13
Abbott India 25,593.30 7,217.19 6,929.05 33.68 43.78
Astrazeneca Phar 6,367.35 2,304.07 2,275.58 93.84 27.86
Glaxosmi. Pharma 2,483.55 3,932.76 3,790.20 39.67 58.17
Novartis India 1,693.85 393.10 354.33 42.77 15.94
Cipla 1,380.00 20,102.60 18,979.95 42.06 13.88
Bliss GVS Pharma 648.40 773.53 729.81 60.26 12.51
Amrutanjan Healt 496.85 520.13 502.55 26.61 24.16
Fermenta Biotec. 417.55 474.15 450.25 19.49 18.77
Guj. Themis Bio. 362.50 168.25 165.82 96.93 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77